Also trades as: 0HVB.L (LSE) · $vol 1M

$59.14

+1.37 (+2.37%)

Weekly Expected Move ±8.7%

$48 $53 $58 $63 $68

NYSE · Healthcare · Medical - Healthcare Plans · Alpha Radar Buy · Power 69 · $29.2B mcap · 458M float · 1.42% daily turnover · Short 43% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

46.8 / 100

NoneWeakNarrowWide

Primary source: Intangible Assets · ROIC: -27.6% · 5Y Avg: 1.3%

Cost Advantage

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. CNC shows a Weak competitive edge (46.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Intangible Assets. Negative ROIC of -27.6% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$40

Low

$60

Avg Target

$80

High

Based on 9 analysts since Apr 28, 2026 earnings

Analyst Recommendations

Strong Buy: 0Buy: 27Hold: 15Sell: 1Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$55.58

Analysts12

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-22	UBS	—	$42	$61	+19	+5.6%	$57.77
2026-05-20	Mizuho Securities	Ann Hynes	$41	$58	+17	-1.9%	$59.15
2026-05-20	Deutsche Bank	—	$39	$80	+41	+35.2%	$59.15
2026-04-29	Truist Financial	—	$49	$58	+9	+10.1%	$52.69
2026-04-29	Oppenheimer	—	$45	$58	+13	+17.0%	$49.57
2026-04-29	Goldman Sachs	Scott Fidel	$38	$40	+2	-19.3%	$49.57
2026-04-29	Barclays	—	$54	$63	+9	+27.1%	$49.57
2026-04-29	Raymond James	Sarah James	Initiated	$60	—	+21.0%	$49.57
2026-04-28	Cantor Fitzgerald	—	Initiated	$60	—	+21.0%	$49.57
2026-04-20	Jefferies	David Windley	$72	$39	-33	+2.2%	$38.16
2026-03-10	Mizuho Securities	Ann Hynes	$47	$41	-6	+12.6%	$36.40
2026-02-25	Truist Financial	—	$45	$49	+4	+14.2%	$42.90
2026-02-18	Wells Fargo	Stephen Baxter	$43	$44	+1	+6.7%	$41.23
2026-02-10	Deutsche Bank	—	$91	$39	-52	-1.8%	$39.72
2026-01-09	Mizuho Securities	—	$40	$47	+7	+0.2%	$46.92
2026-01-07	Wells Fargo	—	$41	$43	+2	-6.0%	$45.74
2026-01-06	Bernstein	—	$45	$59	+14	+30.2%	$45.30
2026-01-05	Barclays	—	$44	$54	+10	+29.2%	$41.78
2025-11-20	Bernstein	—	$36	$45	+9	+29.2%	$34.83
2025-11-04	Barclays	Andrew Mok	$33	$44	+11	+27.5%	$34.50
2025-10-30	Truist Financial	—	$42	$45	+3	+26.4%	$35.62
2025-10-30	UBS	—	$45	$42	-3	+16.3%	$36.12
2025-10-30	Oppenheimer	Michael Wiederhorn	$51	$45	-6	+22.7%	$36.68
2025-10-30	Goldman Sachs	Scott Fidel	$33	$38	+5	+1.8%	$37.34
2025-10-14	Truist Financial	—	$102	$42	-60	+15.5%	$36.35
2025-10-14	Morgan Stanley	—	$112	$38	-74	+5.4%	$36.07
2025-10-14	Goldman Sachs	—	$74	$33	-41	-9.2%	$36.36
2025-10-09	Mizuho Securities	—	$92	$40	-52	+4.0%	$38.45
2025-10-07	Wells Fargo	—	$93	$41	-52	+8.9%	$37.64
2025-09-05	Bernstein	—	Initiated	$36	—	+24.2%	$28.98
2025-09-04	Barclays	Andrew Mok	$91	$33	-58	+9.8%	$30.06
2025-07-15	Oppenheimer	Michael Wiederhorn	$95	$51	-44	+70.0%	$30.00
2025-07-02	UBS	—	Initiated	$45	—	+33.2%	$33.78
2025-04-15	Robert W. Baird	Michael Ha	Initiated	$69	—	+10.8%	$62.28
2024-10-29	Barclays	Andrew Mok	$97	$91	-6	+47.6%	$61.65
2024-09-10	Jefferies	David Windley	$83	$72	-11	+1.4%	$71.00
2024-09-05	Barclays	Andrew Mok	$93	$97	+4	+32.4%	$73.26
2024-07-11	Jefferies	David Windley	$90	$83	-7	+25.0%	$66.38
2024-04-29	Jefferies	David Windley	Initiated	$90	—	+21.9%	$73.83
2024-04-15	Wells Fargo	Stephen Baxter	$99	$93	-6	+27.4%	$73.02
2023-02-08	Goldman Sachs	—	$83	$74	-9	+2.0%	$72.56
2023-02-08	J.P. Morgan	—	$98	$94	-4	+32.4%	$70.98
2023-02-08	Barclays	—	Initiated	$93	—	+31.0%	$70.98
2023-01-06	J.P. Morgan	—	Initiated	$98	—	+24.6%	$78.66
2022-08-26	Wells Fargo	Stephen Baxter	Initiated	$99	—	+3.4%	$95.73
2022-07-27	Mizuho Securities	—	Initiated	$92	—	+0.5%	$91.58
2022-07-27	Credit Suisse	—	$86	$104	+18	+13.6%	$91.55
2022-07-26	Truist Financial	David MacDonald	$96	$102	+6	+11.0%	$91.93
2022-06-22	Deutsche Bank	—	Initiated	$91	—	+12.5%	$80.86
2022-04-27	Morgan Stanley	—	$109	$112	+3	+36.8%	$81.88

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. CNC receives an overall rating of C+. Strongest factors: DCF (5/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).

Rating Change History

Date	From	To
2026-05-12	B-	C+
2026-04-30	C+	B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 38 Grade D

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. CNC scores highest in Safety (65/100) and lowest in Profitability (11/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

2.84

Grey Zone

Piotroski F-Score

6/9

✗ ✓ ✗ ✓ ✗ ✓ ✓ ✓ ✓

Beneish M-Score

-3.64

Unlikely Manipulator

Ohlson O-Score

-6.79

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BBB-

Score: 51.0/100

Trend: Deteriorating

Earnings Quality

—

OCF/NI: -1.11x

Accruals: -17.0%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. CNC scores 2.84, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. CNC scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. CNC's score of -3.64 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. CNC's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. CNC receives an estimated rating of BBB- (score: 51.0/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

-4.52x

PEG

0.02x

P/S

0.15x

P/B

1.36x

P/FCF

2.56x

P/OCF

2.26x

EV/EBITDA

-3.35x

EV/Revenue

0.09x

EV/EBIT

-2.82x

EV/FCF

2.70x

Earnings Yield

-39.71%

FCF Yield

39.11%

Shareholder Yield

2.85%

Graham Number

—

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. CNC currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

1.011

NI / EBT

Interest Burden

1.051

EBT / EBIT

EBIT Margin

-0.031

EBIT / Rev

Asset Turnover

2.475

Rev / Assets

Equity Multiplier

3.453

Assets / Equity

ROE

-27.8%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. CNC's ROE of -27.8% is driven by financial leverage (equity multiplier: 3.45x). Note: high leverage means ROE is amplified by debt rather than operational performance. A tax burden ratio of 1.01 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

0.00%

Fair P/E

8.50x

Intrinsic Value

—

Price/Value

—

Margin of Safety

—

Premium

—

Assessment

Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$59.14

Median 1Y

$55.04

5th Pctile

$26.09

95th Pctile

$115.85

Ann. Volatility

42.8%

Analyst Target

$55.58

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Michael F. Neidorff Chairman and Chief Executive Officer	$850,000	$—	$2,082,493
William N. Scheffel Senior Vice President, Specialty Companies	$317,885	$127,000	$563,509
Karey L. Witty Senior Vice President, Chief Financial Officer,	$317,538	$127,000	$556,256
James D. Donovan, Jr. Senior Vice President, Health Plans	$356,577	$76,200	$536,938
Joseph P. Drozda, Jr., M.D. Executive Vice President, Chief Medical Officer	$380,000	$50,800	$504,162

CEO Pay Ratio

10:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $2,082,493

Avg Employee Cost (SGA/emp): $217,077

Employees: 61,100

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

61,100

+1.0% YoY

Revenue / Employee

$3,187,840

Rev: $194,777,000,000

Profit / Employee

$-109,214

NI: $-6,673,000,000

SGA / Employee

$217,077

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	3.8%	3.8%	5.1%	5.7%	7.1%	7.7%	4.7%	5.8%	10.7%	9.6%	10.8%	11.0%	11.3%	12.3%	12.7%	13.2%	7.9%	-20.2%	-28.8%	-27.8%	-27.79%
ROA	1.3%	1.3%	1.8%	2.0%	2.5%	2.7%	1.5%	1.9%	3.5%	3.1%	3.3%	3.4%	3.5%	3.8%	4.0%	4.1%	2.5%	-6.3%	-8.3%	-8.0%	-8.05%
ROIC	3.1%	2.6%	3.8%	4.2%	5.2%	4.9%	2.6%	2.8%	5.8%	6.2%	8.8%	8.3%	8.6%	8.7%	8.4%	9.4%	4.9%	-15.5%	-28.9%	-27.6%	-27.64%
ROCE	3.8%	3.7%	4.7%	5.1%	5.7%	6.2%	5.4%	6.0%	9.4%	8.9%	9.0%	9.2%	9.4%	9.7%	10.3%	10.8%	7.1%	-8.6%	-11.4%	-10.8%	-10.80%
Gross Margin	10.6%	11.3%	11.2%	11.7%	12.5%	11.1%	10.8%	11.8%	12.0%	12.0%	9.3%	11.5%	11.1%	9.6%	9.1%	11.2%	6.0%	16.4%	15.2%	21.9%	21.90%
Operating Margin	-1.3%	1.7%	1.9%	3.4%	-0.4%	1.3%	-0.8%	3.1%	3.1%	1.9%	-0.5%	2.7%	3.1%	1.6%	0.4%	3.3%	-0.9%	-14.0%	-3.5%	3.7%	3.73%
Net Margin	-1.7%	1.8%	1.8%	2.3%	-0.5%	2.1%	-0.6%	2.9%	2.8%	1.2%	0.1%	2.9%	2.9%	1.7%	0.7%	2.8%	-0.5%	-13.3%	-2.2%	3.1%	3.09%
EBITDA Margin	-0.1%	3.9%	3.8%	4.6%	0.8%	4.3%	1.7%	4.9%	5.1%	3.4%	1.3%	4.8%	5.0%	3.4%	2.0%	4.8%	0.5%	-12.5%	-2.8%	4.5%	4.53%
FCF Margin	2.4%	4.6%	2.6%	3.3%	4.3%	5.3%	3.6%	5.7%	5.2%	3.6%	4.7%	1.7%	1.4%	0.2%	-0.3%	0.9%	0.6%	1.8%	2.2%	3.2%	3.20%
OCF Margin	3.2%	5.3%	3.3%	4.0%	5.1%	6.0%	4.3%	6.4%	5.8%	4.2%	5.2%	2.1%	1.9%	0.6%	0.1%	1.3%	1.0%	2.2%	2.6%	3.6%	3.62%
ROE 3Y Avg	snapshot only																				-2.88%
ROE 5Y Avg	snapshot only																				0.62%
ROA 3Y Avg	snapshot only																				-0.29%
ROIC 3Y Avg	snapshot only																				-3.22%
ROIC Economic	snapshot only																				-16.57%
Cash ROA	snapshot only																				9.24%
Cash ROIC	snapshot only																				34.44%
CROIC	snapshot only																				30.45%
NOPAT Margin	snapshot only																				-2.91%
Pretax Margin	snapshot only																				-3.22%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				6.72%
SBC / Revenue	snapshot only																				0.08%

Valuation

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	59.03	50.01	36.20	33.22	26.55	22.43	38.20	23.61	13.68	15.25	14.77	15.44	12.47	12.85	9.20	8.76	13.04	-3.31	-3.03	-2.52	-4.517
P/S Ratio	0.36	0.30	0.39	0.37	0.36	0.32	0.32	0.24	0.25	0.25	0.26	0.27	0.22	0.24	0.19	0.18	0.15	0.09	0.10	0.08	0.147
P/B Ratio	1.65	1.43	1.82	1.86	1.84	1.69	1.91	1.46	1.54	1.55	1.54	1.63	1.36	1.53	1.15	1.15	1.01	0.66	1.01	0.81	1.358
P/FCF	14.85	6.52	14.80	11.44	8.25	6.03	8.74	4.17	4.85	6.84	5.50	16.22	15.56	160.87	-62.06	20.27	24.81	5.22	4.68	2.56	2.557
P/OCF	11.31	5.65	11.60	9.36	7.07	5.31	7.33	3.73	4.33	5.96	4.95	12.69	11.90	41.14	197.47	14.27	15.49	4.31	3.97	2.26	2.260
EV/EBITDA	15.38	13.50	14.36	13.81	12.78	11.17	12.84	9.72	7.41	7.78	6.97	7.30	5.98	6.56	5.35	5.10	6.28	-7.00	-4.10	-3.35	-3.350
EV/Revenue	0.41	0.35	0.45	0.43	0.42	0.38	0.37	0.29	0.30	0.29	0.25	0.27	0.22	0.24	0.20	0.19	0.17	0.11	0.11	0.09	0.086
EV/EBIT	27.05	24.78	22.91	21.58	19.26	16.27	20.12	14.51	9.66	10.21	9.05	9.41	7.65	8.31	6.69	6.31	8.57	-4.88	-3.29	-2.82	-2.820
EV/FCF	16.92	7.57	17.23	13.28	9.59	7.10	10.05	5.00	5.76	8.11	5.39	15.92	15.22	157.70	-67.66	22.11	27.35	6.04	4.88	2.70	2.697
Earnings Yield	1.7%	2.0%	2.8%	3.0%	3.8%	4.5%	2.6%	4.2%	7.3%	6.6%	6.8%	6.5%	8.0%	7.8%	10.9%	11.4%	7.7%	-30.2%	-33.0%	-39.7%	-39.71%
FCF Yield	6.7%	15.3%	6.8%	8.7%	12.1%	16.6%	11.4%	24.0%	20.6%	14.6%	18.2%	6.2%	6.4%	0.6%	-1.6%	4.9%	4.0%	19.2%	21.4%	39.1%	39.11%
PEG Ratio	snapshot only																				0.020
Price/Tangible Book	snapshot only																				3.537
EV/OCF	snapshot only																				2.384
EV/Gross Profit	snapshot only																				0.579
Shareholder Yield	snapshot only																				2.85%

Leverage & Solvency

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	1.08	1.08	1.11	1.11	1.11	1.11	1.06	1.06	1.06	1.06	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.68	1.68	1.676
Quick Ratio	1.08	1.08	1.11	1.11	1.11	1.11	1.06	1.06	1.06	1.06	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.11	1.68	1.68	1.676
Debt/Equity	0.71	0.71	0.85	0.85	0.85	0.85	0.89	0.89	0.89	0.89	0.73	0.73	0.73	0.73	0.74	0.74	0.74	0.74	0.94	0.94	0.941
Net Debt/Equity	0.23	0.23	0.30	0.30	0.30	0.30	0.29	0.29	0.29	0.29	-0.03	-0.03	-0.03	-0.03	0.10	0.10	0.10	0.10	0.04	0.04	0.045
Debt/Assets	0.27	0.27	0.29	0.29	0.29	0.29	0.28	0.28	0.28	0.28	0.22	0.22	0.22	0.22	0.24	0.24	0.24	0.24	0.24	0.24	0.242
Debt/EBITDA	5.82	5.79	5.73	5.42	5.04	4.76	5.18	4.95	3.59	3.75	3.36	3.32	3.28	3.21	3.13	3.00	4.13	-6.71	-3.65	-3.68	-3.676
Net Debt/EBITDA	1.89	1.88	2.02	1.91	1.78	1.68	1.69	1.61	1.17	1.22	-0.14	-0.14	-0.13	-0.13	0.44	0.42	0.58	-0.95	-0.17	-0.17	-0.174
Interest Coverage	2.58	2.54	3.73	4.08	4.56	5.00	3.95	4.22	6.48	6.05	5.96	6.09	6.27	6.52	7.06	7.53	5.01	-6.09	-9.46	-9.03	-9.030
Equity Multiplier	2.67	2.67	2.92	2.92	2.92	2.92	3.20	3.20	3.20	3.20	3.28	3.28	3.28	3.28	3.12	3.12	3.12	3.12	3.89	3.89	3.892
Cash Ratio	snapshot only																				0.833
Debt Service Coverage	snapshot only																				-7.602
Cash to Debt	snapshot only																				0.953
FCF to Debt	snapshot only																				0.338
Defensive Interval	snapshot only																				356.4 days

Efficiency & Turnover

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	2.16	2.22	1.71	1.81	1.88	1.92	1.86	1.88	1.91	1.93	1.91	1.93	1.95	2.00	1.95	2.03	2.13	2.22	2.43	2.47	2.475
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	14.85	15.27	11.49	12.14	12.59	12.91	11.33	11.47	11.60	11.77	10.69	10.80	10.95	11.23	9.25	9.61	10.11	10.55	10.30	10.48	10.477
Payables Turnover	18.83	19.48	14.56	15.40	15.88	16.29	14.51	14.67	14.86	15.04	10.68	10.79	10.97	11.33	9.99	10.38	11.09	11.33	10.19	10.04	10.044
DSO	25	24	32	30	29	28	32	32	31	31	34	34	33	33	39	38	36	35	35	35	34.8 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DPO	19	19	25	24	23	22	25	25	25	24	34	34	33	32	37	35	33	32	36	36	36.3 days
Cash Conversion Cycle	5	5	7	6	6	6	7	7	7	7	-0	-0	0	0	3	3	3	2	-0	-2	-1.5 days
Fixed Asset Turnover	snapshot only																				84.155
Cash Velocity	snapshot only																				11.075
Capital Intensity	snapshot only																				0.392

Growth (YoY)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	29.3%	19.7%	13.4%	15.7%	16.6%	16.3%	14.7%	9.8%	7.1%	6.0%	6.5%	6.3%	6.6%	7.7%	5.9%	8.9%	13.0%	14.9%	19.4%	17.0%	17.02%
Net Income	-53.7%	-63.7%	-25.5%	-39.2%	1.6%	1.7%	-10.8%	-0.9%	45.9%	21.4%	1.2%	84.4%	4.1%	25.5%	22.3%	26.3%	-27.2%	-2.7%	-3.0%	-2.9%	-2.87%
EPS	-53.4%	-63.9%	-27.0%	-39.3%	1.6%	1.8%	-5.7%	5.6%	54.7%	30.2%	1.3%	89.8%	7.9%	29.7%	31.0%	36.4%	-21.8%	-2.8%	-3.1%	-2.9%	-2.88%
FCF	49.3%	4.6%	-28.9%	-11.4%	1.1%	32.8%	59.5%	93.0%	27.8%	-27.3%	38.0%	-69.0%	-70.4%	-95.5%	-1.1%	-42.7%	-52.2%	12.7%	9.8%	3.3%	3.25%
EBITDA	-22.0%	-34.8%	-16.9%	-25.8%	42.6%	50.3%	4.1%	3.2%	32.4%	19.4%	36.4%	31.6%	-3.2%	3.6%	10.4%	14.0%	-18.3%	-1.5%	-1.8%	-1.8%	-1.79%
Op. Income	-43.1%	-64.2%	-42.1%	-49.8%	50.3%	84.2%	-26.1%	-35.3%	13.7%	29.0%	1.2%	1.2%	11.3%	-1.3%	8.4%	27.9%	-33.4%	-3.0%	-3.4%	-3.0%	-3.02%
OCF Growth	snapshot only																				2.39%
Asset Growth	snapshot only																				-5.80%
Equity Growth	snapshot only																				-24.45%
Debt Growth	snapshot only																				-3.36%
Shares Change	snapshot only																				-0.52%

Growth (CAGR)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue 3Y	31.5%	29.3%	28.0%	26.8%	25.7%	25.1%	24.6%	21.2%	17.3%	13.9%	11.5%	10.6%	10.0%	9.9%	9.0%	8.3%	8.9%	9.5%	10.5%	10.6%	10.64%
Revenue 5Y	31.6%	28.3%	25.4%	24.0%	24.4%	24.4%	24.5%	24.0%	23.2%	21.6%	20.7%	18.9%	17.8%	17.5%	16.9%	15.5%	14.2%	12.8%	11.9%	11.5%	11.48%
EPS 3Y	-22.9%	-16.3%	2.1%	-0.6%	1.6%	2.5%	-11.8%	20.5%	23.0%	9.4%	17.3%	6.8%	62.7%	67.5%	42.5%	39.8%	9.3%	—	—	—	—
EPS 5Y	3.8%	1.1%	7.1%	4.3%	6.9%	7.3%	-1.7%	-1.5%	12.8%	16.3%	18.6%	14.5%	11.8%	12.7%	16.0%	35.3%	9.5%	—	—	—	—
Net Income 3Y	-12.5%	-6.1%	14.4%	11.4%	13.4%	14.2%	-3.1%	20.6%	20.4%	6.4%	14.3%	3.6%	57.7%	60.9%	34.9%	32.1%	3.4%	—	—	—	—
Net Income 5Y	15.0%	12.3%	18.9%	15.7%	18.2%	18.5%	7.7%	7.6%	20.3%	22.4%	24.6%	20.4%	17.2%	17.8%	20.1%	32.5%	5.7%	—	—	—	—
EBITDA 3Y	13.3%	17.7%	21.5%	19.3%	18.3%	18.1%	13.2%	20.0%	13.8%	5.4%	5.7%	0.3%	22.3%	23.0%	16.2%	15.7%	1.5%	—	—	—	—
EBITDA 5Y	25.0%	20.1%	19.1%	16.5%	17.2%	18.2%	18.7%	15.8%	22.4%	24.0%	20.5%	18.2%	16.2%	15.3%	16.9%	21.0%	3.1%	—	—	—	—
Gross Profit 3Y	26.9%	21.6%	19.0%	19.7%	21.3%	22.5%	23.5%	20.5%	11.5%	7.8%	4.4%	3.5%	7.0%	6.5%	5.8%	5.2%	-0.5%	6.8%	12.7%	20.6%	20.56%
Gross Profit 5Y	29.9%	24.9%	20.7%	19.7%	21.3%	22.0%	23.5%	21.0%	19.6%	17.8%	15.5%	14.8%	13.8%	13.4%	13.7%	12.5%	5.4%	7.4%	9.4%	13.5%	13.53%
Op. Income 3Y	-0.8%	-1.5%	7.0%	7.3%	8.9%	5.2%	-9.5%	-0.0%	-1.0%	-5.3%	-1.7%	-10.6%	23.9%	32.9%	21.2%	22.0%	-5.5%	—	—	—	—
Op. Income 5Y	13.6%	4.5%	7.2%	6.0%	8.1%	7.4%	1.9%	-3.1%	10.8%	17.8%	15.0%	11.9%	10.4%	8.2%	12.3%	22.9%	-6.3%	—	—	—	—
FCF 3Y	31.3%	48.9%	80.6%	2.9%	58.7%	1.1%	91.1%	—	58.6%	75.5%	16.1%	-19.0%	-7.6%	-64.9%	—	-30.0%	-43.5%	-23.5%	-6.3%	-8.9%	-8.89%
FCF 5Y	—	95.8%	16.4%	11.2%	17.9%	27.3%	37.6%	40.6%	43.3%	26.1%	67.0%	1.1%	8.6%	-20.8%	—	—	-10.9%	27.2%	-1.4%	5.3%	5.28%
OCF 3Y	26.3%	41.1%	50.5%	96.2%	48.2%	78.4%	61.6%	—	46.5%	49.6%	13.5%	-16.8%	-7.7%	-47.2%	-66.8%	-26.4%	-37.2%	-21.8%	-6.7%	-8.5%	-8.53%
OCF 5Y	1.5%	70.2%	17.8%	12.8%	18.3%	26.4%	33.3%	35.1%	35.6%	22.0%	45.5%	36.4%	6.6%	-8.6%	-36.4%	—	-8.7%	16.8%	-1.6%	4.4%	4.41%
Assets 3Y	46.5%	46.5%	36.4%	36.4%	36.4%	36.4%	23.3%	23.3%	23.3%	23.3%	7.2%	7.2%	7.2%	7.2%	1.7%	1.7%	1.7%	1.7%	0.3%	0.3%	0.34%
Assets 5Y	56.4%	56.4%	31.2%	31.2%	31.2%	31.2%	28.6%	28.6%	28.6%	28.6%	22.3%	22.3%	22.3%	22.3%	15.0%	15.0%	15.0%	15.0%	2.5%	2.5%	2.48%
Equity 3Y	55.5%	55.5%	34.9%	34.9%	34.9%	34.9%	24.2%	24.2%	24.2%	24.2%	0.1%	0.1%	0.1%	0.1%	-0.5%	-0.5%	-0.5%	-0.5%	-6.0%	-6.0%	-6.04%
Book Value 3Y	37.1%	38.7%	20.3%	20.4%	20.8%	21.1%	13.1%	24.1%	27.0%	27.7%	2.7%	3.2%	3.3%	4.2%	5.1%	5.3%	5.2%	5.2%	-1.8%	-2.5%	-2.50%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	0.96	0.96	0.93	0.95	0.97	0.98	0.97	0.98	0.99	0.98	0.97	0.96	0.96	0.96	0.95	0.95	0.97	0.98	0.96	0.97	0.969
Earnings Stability	0.28	0.28	0.75	0.44	0.30	0.30	0.31	0.22	0.49	0.43	0.47	0.43	0.64	0.53	0.59	0.59	0.44	0.25	0.26	0.30	0.299
Margin Stability	0.96	0.92	0.90	0.91	0.94	0.92	0.92	0.91	0.93	0.90	0.89	0.90	0.94	0.94	0.95	0.95	0.86	0.89	0.89	0.84	0.845
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.00	0.00	0.00	0.00	0.50	0.50	0.00	0.00	1.00	1.00	0.50	0.50	1.00	1.00	1.00	1.00	0.00	0.00	0.00	0.00	0.000
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0	1	1	1	0	1	1
Earnings Persistence	0.50	0.50	0.90	0.84	0.50	0.50	0.96	1.00	0.82	0.91	0.50	0.50	0.98	0.90	0.91	0.89	0.89	0.20	0.20	0.20	0.200
Earnings Smoothness	0.27	0.06	0.71	0.51	0.12	0.07	0.89	0.99	0.63	0.81	0.23	0.41	0.96	0.77	0.80	0.77	0.68	—	—	—	—
ROE Trend	-0.09	-0.11	-0.04	-0.03	-0.01	-0.02	-0.01	-0.01	0.06	0.05	0.05	0.05	0.02	0.03	0.05	0.05	-0.03	-0.31	-0.45	-0.44	-0.441
Gross Margin Trend	-0.01	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.00	0.00	-0.00	-0.00	-0.01	-0.01	-0.01	-0.01	-0.02	-0.00	0.01	0.04	0.042
FCF Margin Trend	0.00	0.04	0.00	0.02	0.02	0.02	0.00	0.02	0.02	-0.01	0.02	-0.03	-0.03	-0.04	-0.04	-0.03	-0.03	-0.00	0.00	0.02	0.019
Sustainable Growth Rate	3.8%	3.8%	5.1%	5.7%	7.1%	7.7%	4.7%	5.8%	10.7%	9.6%	10.8%	11.0%	11.3%	12.3%	12.7%	13.2%	7.9%	—	—	—	—
Internal Growth Rate	1.3%	1.4%	1.9%	2.1%	2.6%	2.8%	1.6%	1.9%	3.6%	3.3%	3.5%	3.5%	3.6%	3.9%	4.1%	4.3%	2.5%	—	—	—	—

Cash Flow Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	5.22	8.85	3.12	3.55	3.75	4.23	5.21	6.32	3.16	2.56	2.98	1.22	1.05	0.31	0.05	0.61	0.84	-0.77	-0.76	-1.11	-1.114
FCF/OCF	0.76	0.87	0.78	0.82	0.86	0.88	0.84	0.89	0.89	0.87	0.90	0.78	0.76	0.26	-3.18	0.70	0.62	0.83	0.85	0.88	0.884
FCF/Net Income	snapshot only																				-0.985
CapEx/Revenue	0.8%	0.7%	0.7%	0.7%	0.7%	0.7%	0.7%	0.7%	0.6%	0.5%	0.5%	0.5%	0.4%	0.4%	0.4%	0.4%	0.4%	0.4%	0.4%	0.4%	0.42%
CapEx/Depreciation	snapshot only																				0.867
Accruals Ratio	-0.06	-0.11	-0.04	-0.05	-0.07	-0.09	-0.07	-0.10	-0.08	-0.05	-0.07	-0.01	-0.00	0.03	0.04	0.02	0.00	-0.11	-0.15	-0.17	-0.170
Sloan Accruals	snapshot only																				0.123
Cash Flow Adequacy	snapshot only																				8.627

Dividends & Buybacks

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—	—	—
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	13.6%	14.3%	22.0%	22.6%	36.8%	94.9%	2.6%	2.3%	1.3%	1.2%	60.4%	49.8%	62.3%	72.1%	94.5%	87.3%	1.3%	—	—	—	—
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.2%	0.3%	0.6%	0.7%	1.4%	4.2%	6.7%	9.8%	9.4%	8.1%	4.1%	3.2%	5.0%	5.6%	10.3%	10.0%	9.9%	8.1%	2.4%	2.9%	2.85%
Net Buyback Yield	0.2%	0.3%	0.6%	0.7%	1.4%	4.2%	6.6%	9.6%	9.2%	7.9%	4.0%	3.1%	4.9%	5.5%	10.1%	9.8%	9.7%	7.9%	2.2%	2.6%	2.63%
Total Shareholder Return	0.2%	0.3%	0.6%	0.7%	1.4%	4.2%	6.6%	9.6%	9.2%	7.9%	4.0%	3.1%	4.9%	5.5%	10.1%	9.8%	9.7%	7.9%	2.2%	2.6%	2.63%

DuPont Factors

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	0.66	0.70	0.74	0.74	0.80	0.77	0.61	0.67	0.70	0.68	0.75	0.74	0.75	0.78	0.78	0.76	0.75	1.09	0.99	1.01	1.011
Interest Burden (EBT/EBIT)	0.61	0.61	0.73	0.76	0.78	0.80	0.75	0.76	0.85	0.83	0.83	0.84	0.84	0.85	0.86	0.87	0.80	1.16	1.05	1.05	1.051
EBIT Margin	0.02	0.01	0.02	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.03	0.02	-0.02	-0.03	-0.03	-0.031
Asset Turnover	2.16	2.22	1.71	1.81	1.88	1.92	1.86	1.88	1.91	1.93	1.91	1.93	1.95	2.00	1.95	2.03	2.13	2.22	2.43	2.47	2.475
Equity Multiplier	2.86	2.86	2.80	2.80	2.80	2.80	3.05	3.05	3.05	3.05	3.24	3.24	3.24	3.24	3.20	3.20	3.20	3.20	3.45	3.45	3.453

Per Share

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$1.24	$1.25	$2.28	$2.53	$3.19	$3.47	$2.15	$2.68	$4.93	$4.52	$5.03	$5.08	$5.32	$5.86	$6.58	$6.93	$4.16	$-10.77	$-13.59	$-13.00	$-13.00
Book Value/Share	$44.22	$43.63	$45.28	$45.36	$45.91	$46.15	$42.96	$43.44	$43.72	$44.45	$48.06	$48.02	$48.69	$49.36	$52.61	$53.01	$53.51	$53.77	$40.63	$40.26	$43.75
Tangible Book/Share	$-2.17	$-2.14	$-1.35	$-1.35	$-1.37	$-1.38	$-2.98	$-3.01	$-3.03	$-3.08	$4.06	$4.05	$4.11	$4.17	$6.86	$6.91	$6.98	$7.01	$9.34	$9.26	$9.26
Revenue/Share	$203.13	$206.03	$212.89	$225.48	$236.61	$243.80	$258.15	$264.06	$268.80	$277.31	$286.45	$289.03	$297.21	$308.91	$324.86	$339.80	$361.04	$378.42	$396.64	$399.73	$402.59
FCF/Share	$4.91	$9.55	$5.57	$7.36	$10.25	$12.91	$9.39	$15.15	$13.90	$10.07	$13.49	$4.84	$4.26	$0.47	$-0.98	$2.99	$2.19	$6.83	$8.80	$12.80	$12.90
OCF/Share	$6.45	$11.02	$7.11	$9.00	$11.96	$14.66	$11.18	$16.93	$15.57	$11.57	$14.98	$6.19	$5.57	$1.83	$0.31	$4.26	$3.51	$8.27	$10.36	$14.48	$14.59
Cash/Share	$21.24	$20.96	$24.77	$24.81	$25.11	$25.24	$25.71	$25.99	$26.16	$26.59	$36.55	$36.52	$37.03	$37.54	$33.24	$33.49	$33.81	$33.97	$36.43	$36.09	$48.25
EBITDA/Share	$5.40	$5.36	$6.68	$7.08	$7.70	$8.20	$7.35	$7.79	$10.80	$10.50	$10.45	$10.55	$10.84	$11.25	$12.35	$12.99	$9.53	$-5.90	$-10.47	$-10.31	$-10.31
Debt/Share	$31.43	$31.01	$38.29	$38.37	$38.83	$39.03	$38.10	$38.52	$38.77	$39.41	$35.11	$35.08	$35.57	$36.06	$38.70	$39.00	$39.37	$39.56	$38.24	$37.89	$37.89
Net Debt/Share	$10.19	$10.05	$13.53	$13.55	$13.71	$13.79	$12.39	$12.53	$12.61	$12.82	$-1.44	$-1.44	$-1.46	$-1.48	$5.47	$5.51	$5.56	$5.59	$1.81	$1.79	$1.79

Academic Models

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	2.843
Altman Z-Prime	snapshot only																				1.361
Piotroski F-Score	5	4	6	6	8	8	5	7	6	7	8	8	7	7	5	5	4	5	6	6	6
Beneish M-Score	-1.53	-1.97	-2.37	-2.47	-2.67	-2.64	-2.71	-2.91	-2.76	-2.69	-2.55	-2.36	-2.29	-2.08	-2.03	-2.13	-1.75	-2.97	-3.44	-3.64	-3.641
Ohlson O-Score	snapshot only																				-6.786
ROIC (Greenblatt)	snapshot only																				-35.97%
Net-Net WC	snapshot only																				$-43.61
EVA	snapshot only																				$-7844386250.00

Credit

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only																				BBB-
Credit Score	46.60	53.17	47.31	52.63	53.58	64.09	55.41	61.59	66.30	61.94	68.53	62.97	62.55	57.64	58.93	59.42	55.27	44.36	48.55	51.00	51.002
Credit Grade	snapshot only																				10
Credit Trend	snapshot only																				-8.413
Implied Spread (bps)	snapshot only																				350.000
Industry Credit Rank	snapshot only																				33
Sector Credit Rank	snapshot only																				47

CNC NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet